Neuroimmune semaphorin 4A as a drug and drug target for asthma

MLA

Louis J. DeTolla, et al. “Neuroimmune Semaphorin 4A as a Drug and Drug Target for Asthma.” International Immunopharmacology, vol. 17, no. 3, June 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3904921a4920c9ecc7757f68f0d8acd5&authtype=sso&custid=ns315887.

APA

Louis J. DeTolla, Svetlana P. Chapoval, E. Davila, Elizabeth P. Smith, E.H. Nkyimbeng-Takwi, Achsah D. Keegan, G. Mogie, Michael M. Lipsky, & Kathleen Shanks. (2013). Neuroimmune semaphorin 4A as a drug and drug target for asthma. International Immunopharmacology, 17(3).

Chicago

Louis J. DeTolla, Svetlana P. Chapoval, E. Davila, Elizabeth P. Smith, E.H. Nkyimbeng-Takwi, Achsah D. Keegan, G. Mogie, Michael M. Lipsky, and Kathleen Shanks. 2013. “Neuroimmune Semaphorin 4A as a Drug and Drug Target for Asthma.” International Immunopharmacology 17 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3904921a4920c9ecc7757f68f0d8acd5&authtype=sso&custid=ns315887.